Cover Image
Market Research Report

Plastic Prefillable Syringes, June 2015

Published by Greystone Research Associates Product code 332038
Published Content info
Delivery time: 1-2 business days
Back to Top
Plastic Prefillable Syringes, June 2015
Published: June 1, 2015 Content info:

Evolution - or Revolution - in Injectable Devices

The trend toward patient self-administration of injectables continues to have a broad influence on the drug delivery sector. While prefillable syringe manufacturers continue to improve and refine their products, from a materials technology standpoint the most dynamic developments are occurring in the refinement of PFS constructed of plastic rather than glass. To date, plastic PFS have made significant inroads in EMS injectables, a segment dominated by Hospira's Ansyr plastic PFS product line. Now, as materials technology continues to advance, market sector participants are targeting mainstream therapeutic drugs.


  • What injectable drugs are currently delivered in plastic prefillable syringes, what are the device specifics, and who markets them?
  • Who are the important plastic prefillable syringe suppliers, their manufacturing infrastructure and locations, their capabilities?
  • What are the major factors driving plastic prefillable syringe demand?
  • How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
  • What are the essential design factors, material selection issues, technologies and market development issues for plastic prefillable syringe drug products?
  • How are plastic prefillable syringes aligned with various drug classes and therapeutic markets?
  • What are the significant economic, technology, and regulatory factors affecting plastic prefillable syringes?

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.

Table of Contents
Product Code: PPS885R

Table of Contents

  • Executive Summary
  • The Market Opportunity
  • Market Dynamics
  • The Trend toward Self-Administration
  • Shifting Demographics
  • Innovation in Disposable Device Designs
  • The Economics of Plastic Prefilled Syringes
  • What's Driving Interest in Plastic PFS?
  • Limitations of Glass
  • Injectable Drug Volumes and Viscosities
  • Therapeutic Demand Drivers
  • Competitive Landscape
  • Risk Factors
  • Plastic Prefillable Syringe Application Segments
    • Emergency Drugs
    • Diluents
    • Infusion
    • Hyaluronic Acid
    • Specialty Injectables
  • Plastic Prefillable Syringe Design & Technology Factors
  • Materials of Construction
    • Crystal Clear Polymer (CCP)
    • Cyclic Olefin Polymer (COP)
    • Cyclic Olefin Copolymer (COC)
    • Syringe Processing Technology
      • Molding
      • Syringe Coatings
  • Plastic Prefillable Syringe Brands
    • Cyclic Olefin Copolymer (COC)
    • Cyclic Olefin Polymer (COP)
    • Crystal Clear Polymer (CCP)
    • Unbranded Plastic Prefillable Syringes
  • Approved Plastic Prefilled Syringe Products
    • Cyclic Olefin Syringes
    • Other Plastic Syringes
    • Prefilled Syringe Supply Chain
      • Plastics Suppliers
      • Injection Molders
  • Market Factors
  • Regulatory Issues
  • Industry Standards
    • ISO 10993-1
    • USP Class VI
  • Plastic Syringe/Injection Device Integration
  • Patient Compliance and Ease of Use
  • Healthcare Economics
  • Company Profiles
Back to Top